Home Galena Biopharma Earns "Buy" Rating from Roth Capital
 

Keywords :   


Galena Biopharma Earns "Buy" Rating from Roth Capital

2015-05-24 06:48:06| Biotech - Topix.net

's stock had its "buy" rating reiterated by equities researchers at Roth Capital in a research report issued on Friday. They currently have a $8.00 price target on the biotechnology company's stock.

Tags: buy rating capital roth

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05Unpaid carers being forced to repay 250m to DWP
18.05Weekly Recap: Hempel, Axalta, KANSAI HELIOS Top This Weeks Stories
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
More »